These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29704804)

  • 21. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of qnr genes in clinical Enterobacteriaceae non-susceptible to fluoroquinolone in Poland].
    Piekarska K; Rzeczkowska M; Zacharczuk K; Chróst A; Januszkiewicz A; Bareja E; Olak M; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(3):211-9. PubMed ID: 23285775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
    Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
    Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken Escherichia coli isolates from 2001 to 2007.
    Huang SY; Dai L; Xia LN; Du XD; Qi YH; Liu HB; Wu CM; Shen JZ
    Foodborne Pathog Dis; 2009 Dec; 6(10):1203-9. PubMed ID: 19735206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X; Quinn B; Kerns R; Drlica K
    J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between occurrence of plasmid-mediated quinolone resistance and ciprofloxacin resistance in Escherichia coli isolates of different origins.
    Yang T; Zeng Z; Rao L; Chen X; He D; Lv L; Wang J; Zeng L; Feng M; Liu JH
    Vet Microbiol; 2014 May; 170(1-2):89-96. PubMed ID: 24553411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolone Resistance Mechanisms by Molecular Epidemiologic Study of Ciprofloxacin-Nonsusceptible
    Yang HS; Kim Y; Cho SY; Nam YS; Oh TS; Park KS; Kim HC; Lee HJ
    Ann Clin Lab Sci; 2017 Aug; 47(4):511-515. PubMed ID: 28801381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli.
    Garoff L; Yadav K; Hughes D
    J Antimicrob Chemother; 2018 Feb; 73(2):348-352. PubMed ID: 29106520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic Resistance Characterization of Environmental
    Dhawde R; Macaden R; Saranath D; Nilgiriwala K; Ghadge A; Birdi T
    Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29895787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of Resistant Bacteria in Mallards Exposed to Subinhibitory Concentrations of Ciprofloxacin in Their Water Environment.
    Atterby C; Nykvist M; Lustig U; Andersson DI; Järhult JD; Sandegren L
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
    Vinué L; Corcoran MA; Hooper DC; Jacoby GA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli.
    Machuca J; Ortiz M; Recacha E; Díaz-De-Alba P; Docobo-Perez F; Rodríguez-Martínez JM; Pascual Á
    J Antimicrob Chemother; 2016 Nov; 71(11):3066-3071. PubMed ID: 27494906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparison of MAMA PCR and SSCP PCR to study chromosomal resistance against Ciprofloxacin and Nalidixic acid in Escherichia coli and Klebsiella pneumoniae.
    Hashemi B; Abdollahi M; Rafiei A; Pormohammad A; Ahanjan M; Moghadaszadeh M; Rashidian S
    Microb Pathog; 2018 Jul; 120():181-186. PubMed ID: 29742463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of subinhibitory ciprofloxacin concentrations on the abundance of qnrS and composition of bacterial communities from water supply reservoirs.
    Marti E; Huerta B; Rodríguez-Mozaz S; Barceló D; Balcázar JL; Marcé R
    Chemosphere; 2016 Oct; 161():470-474. PubMed ID: 27459158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin-resistant Escherichia coli isolated from the intestinal microbiota of goats in Greece in the absence of selective pressure.
    Filioussis G; Tzivara A; Petridou E; Giadinis ND; Burriel AR; Kritas SK
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):352-5. PubMed ID: 23623041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S; Tandon V
    Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Emergence of Quinolone Resistant Shigella sonnei, Pondicherry, India.
    Das A; Natarajan M; Mandal J
    PLoS One; 2016; 11(8):e0160290. PubMed ID: 27494616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.